Skip to Main Content
Hospital Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: As we launch new branding in the coming months, you will see updates to the logos. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. GLP-1

GLP-1

  • Diabetes (380)
    • Blood Glucose Meters (3)
    • Complications (133)
    • Diabetes in Pregnancy (6)
    • Diabetes Meds (66)
    • Drug-Induced Hypo/Hyperglycemia (112)
    • Monitoring (77)
    • Natural Medicines/Supplements (4)
    • Prevention (26)
    • Treatment (228)
      • Alpha-Glucosidase Inhibitors (19)
      • Amylin Agonist (12)
      • Bromocriptine (7)
      • Combination Products (10)
      • Gliptins (59)
      • Glitazones (85)
      • GLP-1 (33)
      • Incretin Enhancers/Mimetics (50)
      • Insulin (122)
      • Meglitinides (32)
      • Metformin (99)
      • SGLT2 Inhibitors (71)
      • Sulfonylureas (81)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (10)
  • Hyperglycemia (35)
  • Hypoglycemia (20)
  • Other (16)
  • Prediabetes (1)
  • Resources (172)
  • Thyroid Disorders (24)
31 - 33 of 33 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: DPP-4 Inhibitors (Gliptins) and Risk of Heart Failure June 2016
Other: Pharmacologic Management of Type 2 Diabetes: 2016 Interim Update June 2016
Patient Education: Heart Failure Meds and More October 2013
  • « Prev
  • 1
  • 2
  • 3
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved